Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with cholangiocarcinoma (a type of cancer affecting the bile ducts in the liver).
- Your liver is functioning at a good level, classified by doctors as "Child-Pugh Class A" (confirm with trial site).
- You are planned to receive a specific combination of cancer treatments (gemcitabine, oxaliplatin, lenvatinib, and a type of immunotherapy drug) followed by a surgical procedure to remove part of the liver, with enough healthy liver remaining afterward.
- You are between 18 and 75 years old, of any gender.
- You are willing and able to take either spirulina (a natural supplement) or a placebo by mouth for 3 weeks before and 3 weeks after your surgery, as part of the study.
- You are willing to follow all parts of the study plan and sign a consent form agreeing to take part.
- You have not had any new sudden illness or significant worsening of symptoms in the 4 weeks before joining the trial.
Who may not be able to join:
- You have serious ongoing health conditions that are not well controlled, such as heart, lung, kidney, or blood disorders.
- You have a known allergy to spirulina or any of its ingredients.
- You have been diagnosed with another type of cancer at the same time.
- You have previously had surgery to remove part of your liver.
- You have a severe mental health condition that could affect your ability to follow the study plan or give informed consent.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 18768161626
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Alanine Aminotransferase (ALT) Level; Change in Aspartate Aminotransferase (AST) Level; Change in Total Bilirubin (TBIL) Level
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.